Can mycophenolic acid dose requirement during the first transplant help predict dosing for the second transplant?
We describe the pharmacokinetic profile of mycophenolic acid (MPA) in a patient receiving Mycophenolate mofetil (MMF) during her first and second renal transplantations. The MMF dose required to achieve a therapeutic range of MPA-AUC(0)(-)(12)(h) early following the second transplantation was 10 times greater than that required late following the first transplantation. Her MMF requirement then declined and continued to decrease even beyond 1 year. Intra-individual variability in MPA profiles precluded the ability to predict MMF dosing for the second transplant based on that during the first. Therapeutic drug monitoring of MMF should be continued beyond 1 year of transplantation.
Annapandian
Vellaichamy M
VM
Department of Nephrology, Christian Medical College, Vellore, India.
Basu
Gopal
G
Mathew
Binu S
BS
Fleming
Denise H
DH
Jacob
Chakko K
CK
John
George T
GT
D000328:Adult; D019540:Area Under Curve; D016903:Drug Monitoring; D005260:Female; D006801:Humans; D016030:Kidney Transplantation; D009173:Mycophenolic Acid / Q000008:administration & dosage*
D009173:Mycophenolic Acid